Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 55: 1467-1473, 1983;
8750-7587/83 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stanbrook, H. S.
Right arrow Articles by McMurtry, I. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stanbrook, H. S.
Right arrow Articles by McMurtry, I. F.

Journal of Applied Physiology, Vol 55, Issue 5 1467-1473, Copyright © 1983 by American Physiological Society

ARTICLES

Inhibition of glycolysis potentiates hypoxic vasoconstriction in rat lungs

H. S. Stanbrook and I. F. McMurtry

The purpose of this study was to test whether inhibition of glycolysis would potentiate hypoxic vasoconstriction in isolated rat lungs, and, if so, to evaluate whether potentiation was due to decreased aerobic production of the mitochondrial substrate, pyruvate, or to inhibition of anaerobic synthesis of ATP. In blood-perfused lungs, both iodoacetate and 2-deoxyglucose inhibited lactate production and increased pressor responses to ventilation with gases containing from 15 to 3% O2. In lungs perfused with physiological salt solution, both 2-deoxyglucose and glucose-free perfusion inhibited lactate and pyruvate production and potentiated the dose-response curve to hypoxia. Dose responses to angiotensin II and KCl were not increased by glucose-free perfusion. Lungs perfused with glucose-free salt solution containing increased levels of lactate and pyruvate did not show an increased dose response to hypoxia. In contrast, lungs perfused with the inhibitor of citric acid cycle, malonate, in addition to the increased lactate and pyruvate, did show an increased dose response to hypoxia. These results indicate that potentiation of hypoxic vasoconstriction by inhibition of glucose metabolism is due to decreased production of pyruvate, rather than to decreased glycolytic generation of ATP. The potentiation might be directly related to either limitation of mitochondrial oxidative phosphorylation in an oxygen-sensing cell or to a decreased level of some intra- or intercellular modulating peptide, fatty acid, or lipid.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Cell Physiol.Home page
Y.-X. Wang, Y.-M. Zheng, I. Abdullaev, and M. I. Kotlikoff
Metabolic inhibition with cyanide induces calcium release in pulmonary artery myocytes and Xenopus oocytes
Am J Physiol Cell Physiol, February 1, 2003; 284(2): C378 - C388.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
M. V. Cutaia and S. Rounds
Analytic Reviews : Hypoxic Pulmonary Vasoconstriction: Physiology and Pathophysiology
J Intensive Care Med, September 1, 1989; 4(5): 186 - 191.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online